Drug-induced arrhythmias: a scientific statement from the American Heart Association
JE Tisdale, MK Chung, KB Campbell, M Hammadah… - Circulation, 2020 - Am Heart Assoc
Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous
antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as …
antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as …
Mouse models of atherosclerosis: a historical perspective and recent advances
YT Lee, HY Lin, YWF Chan, KHC Li, OTL To… - Lipids in health and …, 2017 - Springer
Atherosclerosis represents a significant cause of morbidity and mortality in both the
developed and developing countries. Animal models of atherosclerosis have served as …
developed and developing countries. Animal models of atherosclerosis have served as …
The Tpeak− Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis
Background The T peak− T end interval (the interval from the peak to the end of the T wave),
an electrocardiographic marker reflecting transmural dispersion of repolarization, has been …
an electrocardiographic marker reflecting transmural dispersion of repolarization, has been …
Human engineered heart tissue models for disease modeling and drug discovery
The emergence of human induced pluripotent stem cells (hiPSCs) and efficient
differentiation of hiPSC-derived cardiomyocytes (hiPSC-CMs) induced from diseased …
differentiation of hiPSC-derived cardiomyocytes (hiPSC-CMs) induced from diseased …
[HTML][HTML] Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies
Brugada syndrome (BrS) is an inherited ion channel channelopathy predisposing to
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …
Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy
G Yu, S Chakrabarti, M Tischenko, AL Chen… - Science Translational …, 2022 - science.org
Brugada syndrome (BrS) is a fatal arrhythmia that causes an estimated 4% of all sudden
death in high-incidence areas. SCN5A encodes cardiac sodium channel NaV1. 5 and …
death in high-incidence areas. SCN5A encodes cardiac sodium channel NaV1. 5 and …
Diffuse fibrosis and repolarization disorders explain ventricular arrhythmias in Brugada syndrome: a computational study
N Biasi, P Seghetti, A Tognetti - Scientific Reports, 2022 - nature.com
In this work, we reported a computational study to quantitatively determine the individual
contributions of three candidate arrhythmic factors associated with Brugada Syndrome. In …
contributions of three candidate arrhythmic factors associated with Brugada Syndrome. In …
[HTML][HTML] ST elevation: Differential diagnosis and caveats. A comprehensive review to help distinguish ST elevation myocardial infarction from nonischemic etiologies of …
EC de Bliek - Turkish journal of emergency medicine, 2018 - Elsevier
Prompt diagnosis of acute ST segment elevation myocardial infarction (STEMI) by the initial
ECG is important in order to perform an urgent coronary angiography as soon as possible …
ECG is important in order to perform an urgent coronary angiography as soon as possible …
Incorporating latent variables using nonnegative matrix factorization improves risk stratification in Brugada syndrome
Background A combination of clinical and electrocardiographic risk factors is used for risk
stratification in Brugada syndrome. In this study, we tested the hypothesis that the …
stratification in Brugada syndrome. In this study, we tested the hypothesis that the …
The emergence of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a platform to model arrhythmogenic diseases
M Pourrier, D Fedida - International journal of molecular sciences, 2020 - mdpi.com
There is a need for improved in vitro models of inherited cardiac diseases to better
understand basic cellular and molecular mechanisms and advance drug development. Most …
understand basic cellular and molecular mechanisms and advance drug development. Most …